Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06561217 · ClinicalTrials.gov registry record
Assessing the Performance of Artificial Intelligence (AI)-Augmented Electronic Health Record (EHR) Data Abstraction for Clinical Trial Patient Screening
A clinical trial, sponsored by University of Pennsylvania.
- Completed
- Registry status
- 355
- Enrollment target
NCT06561217: Completed study, sponsored by University of Pennsylvania.
NCT06561217 is a clinical trial that has completed, run by University of Pennsylvania. The registered enrollment target is 355 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06561217 has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- 355 participants
- Enrollment target
Study Summary
Identifying eligible patients is a key process in the clinical trial enterprise. Currently, this process relies on time-intensive manual chart review, creating a rate-limiting step for trial participation. The integration of AI technology into the trial screening process has potential to improve participation rates. This study aims to assess the performance (accuracy, efficiency) of AI-augmented patient identification and inform optimal integration into clinical research screening processes.
Primary Outcome
The primary outcome measured was mean chart-level accuracy, defined as the percentage of elements identified by clinical research coordinators among all elements in the gold-standard set, measured for each chart, and averaged across all charts. Research coordinator-abstracted responses were identified as being accurate when they exactly matched with the gold-standard set. The gold-standard set was determined by 2-3 clinicians blinded to experimental arms.
Interventions
- OTHER Chart review
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 355 participants |
| Start Date | 2023-08-18 |
| Est. Completion | 2024-07-12 |
What the finished NCT06561217 record still lists
NCT06561217 is an observational study that tracks outcomes without assigning an intervention. The registered 355 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Chart review is the first listed.
NCT06561217 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06561217 about?
NCT06561217 is a clinical study titled "Assessing the Performance of Artificial Intelligence (AI)-Augmented Electronic Health Record (EHR) Data Abstraction for Clinical Trial Patient Screening". Identifying eligible patients is a key process in the clinical trial enterprise. Currently, this process relies on time-intensive manual chart review, creating a rate-limiting step for trial participation. The integration of AI technology into the trial screening process has potential to improve par...
What is the current status of trial NCT06561217?
This trial is currently completed. The enrollment target is 355 participants. The study started on 2023-08-18. Estimated completion is 2024-07-12.
What interventions are being tested in trial NCT06561217?
The interventions under investigation include: Chart review (OTHER).
Who is sponsoring clinical trial NCT06561217?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT07133308 · 355 participants · Phase 3
Study to Evaluate the Efficacy and Safety of Deuruxolitinib in Adolescents With Severe Alopecia Areata
- NCT07193511 · 355 participants · Phase 1
BEACON-1: Study of AVZO-103 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Urothelial Cancer or Other Solid Tumors (AVZO-103-1001)
- NCT06077838 · 356 participants · NA
RELAXaHEAD for Headache Patients (Phase III)
- NCT06293469 · 356 participants · NA
Accelerated Flap Coverage in Severe Lower Extremity Trauma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI